卫材

Ageism refers to stereotypes, prejudice and discrimination toward others or ourselves based on age. This #AgeismAwarenessDay, join our partner, the American Society on Aging, to #TalkAboutAgeism and reframe how we discuss aging and older adults in our communities. Learn how you can help #EndAgeism: https://bit.ly/3PKQcKf #LifeAtEisai

We are proud to share that Dr. Michael Irizarry, SVP and Deputy Chief Clinical Officer, has been named a 2024 PharmaVoice 100 Trailblazer!? This distinction honors industry leaders reshaping the pharma world. Dr. Irizarry has demonstrated this through his relentless commitment to addressing the unmet needs of people living with Alzheimer’s disease (AD) through innovative treatments that can help manage the earliest symptomatic stages of AD. Learn more here: https://bit.ly/4gZ7ChO

The Alzheimer's Foundation of America Educating America Tour connects communities across the country with information about #AlzheimersDisease, brain health, caregiving and more. We’re honored to sponsor such an impactful event where people can learn, make connections and hear stories from those who understand their experiences. Thank you for having us, AFA! #LifeAtEisai

Michael Irizarry, MD, MPH, Senior Vice President and Deputy Chief Clinical Officer of Eisai Neurology, had a conversation with Sharon Cohen, MD, FRCPC, and David Weisman, MD, about deriving clinical meaningfulness from Alzheimer’s disease (AD) clinical trials. View their discussion: https://bit.ly/3TSSUz7

We’re proud to support our local #AlzheimersDisease (AD) advocacy partners! Team Eisai walked with both Alzheimer's Foundation of America and Alzheimer's New Jersey to raise funds and support their missions to provide resources and education for those affected by AD and dementia. These events are a powerful testament to our community's commitment to AD research and care. Walking alongside passionate individuals, care partners and families is inspiring and reaffirms our dedication to making strides toward a world without AD. #LifeAtEisai

This #LiverCancerAwarenessMonth and #HispanicHeritageMonth is a time to recognize the higher prevalence of liver cancer among the Hispanic and Latin communities. According to a study from the American Cancer Society, Hispanics and Latinos suffer higher rates of liver cancer—a most often infection-related —than their white peers. ? We’re proud to support the Global Liver Institute’s #OctoberIs4Livers program—the first and only global program of its kind—that spreads awareness around liver cancer. The program’s goals this year are to increase liver cancer awareness, enhance public education, and expand global advocacy. You can learn more on the Global Liver Institute’s website; https://bit.ly/3RCiO6l

Our Exton team visited the Carversville Farm Foundation to help cut and package onions for RMHC of the Philadelphia Region and local soup kitchens in Pennsylvania, New Jersey and Delaware. All produce grown on the farm is donated, and we’re proud to support their mission to provide fresh, nourishing food for the community. #LifeAtEisai

We’ve had the pleasure of sponsoring and attending several events hosted by our oncology advocacy partners. Thank you to SHARE Cancer Support, Prevent Cancer Foundation, HEADstrong Foundation and Leslie’s Week for your ongoing collaboration and commitment to #cancer support and research. We’re dedicated to supporting those affected by cancer and working tirelessly towards breakthroughs that improve lives. #LifeAtEisai

We welcomed Shola Kaye, award-winning international speaker and author on communication, leadership and empathy, to the hhceco Center. She highlighted how creating inclusive and welcoming workplaces not only empowers individuals to step into leadership but also enhances team performance and drives organizational success. Shola’s insights and strategies for fostering empathy and inclusivity have inspired us to continue building a culture where everyone can thrive. #LifeAtEisai

Today is #InternationalDayOfOlderPersons – a day to raise awareness about the opportunities and challenges that aging populations face. Working toward solutions for these difficulties fuels our #AlzheimersDisease (AD) research. Learn more about our commitment: https://bit.ly/3GDVQsk #EndAlz